Trials / Completed
CompletedNCT02342470
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
A Multi-center, Randomized, Double-blind, Parallel, Placebo-controlled, Dose-finding, Phase IIa Clinical Trial to Efficacy and Safety of PMK-S005 for the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- PharmaKing · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety by comparing prevention of recurrent peptic ulcer in low-dose aspirin users between PMK-S005 and Placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Drug : Placebo |
| DRUG | PMK-S005 1 | Drug : PMK-S005 1 (50mg) |
| DRUG | PMK-S005 2 | Drug : PMK-S005 2 (100mg) |
| DRUG | PMK-S005 3 | Drug : PMK-S005 3 (150mg) |
Timeline
- Start date
- 2014-11-24
- Primary completion
- 2017-12-08
- Completion
- 2017-12-08
- First posted
- 2015-01-21
- Last updated
- 2018-01-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02342470. Inclusion in this directory is not an endorsement.